Evidence map›Paper›PMID 21913308›Full record

ArticleGenesis (New York, N.Y. : 2000)2012

Cre-mediated recombination can induce apoptosis in vivo by activating the p53 DNA damage-induced pathway.

Jianjian Zhu, Minh-Thanh Nguyen, Eiichiro Nakamura, Junming Yang, Susan Mackem

Open access · greenAbstract read
In one paragraph

Article in Genesis (New York, N.Y. : 2000), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Chemogenetics as a neuromodulatory approach to treating neuropsychiatric diseases and disorders.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Beyond knockouts: cre resources for conditional mutagenesis.Mammalian genome : official journal of the International Mammalian Genome Society · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Jianjian ZhuCancer and Developmental Biology Laboratory, Center for Cancer Research, NCI-Frederick, Frederick, Maryland 21702, USA.
Minh-Thanh Nguyen
Eiichiro Nakamura
Junming Yang
Susan Mackem
Center for Cancer Research · US

Funding

Role of Shh in developmental patterning and proliferation of digit skeletonZIABC011118 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MACKEM, SUSAN · 2009 to 2025
$7.6M
Intramural NIH HHS Z99 CA999999Intramural NIH HHS ZIA BC011118NCI NIH HHS Y99 CA999999
6 · The paper itself

Abstract

Cre-mediated apoptosis has been observed in many contexts in mice expressing Cre-recombinase and can confound the analysis of genetically engineered conditional mutant or transgenic alleles. Several mechanisms have been proposed to explain this phenomenon. We find that the degree of apoptosis induced correlates roughly with the copy number of loxP sites present in the genome and that some level of increased apoptosis accompanies the presence of even only a few loxP sites, as occurs in conditional floxed alleles. Cre-induced apoptosis in this context is completely p53-dependent, suggesting that the apoptosis is stimulated by p53 activation in response to DNA damage incurred during the process of Cre-mediated recombination.

Indexed as

ApoptosisDNA DamageRecombination, GeneticAllelesAnimalsGene DosageIntegrasesMiceMice, TransgenicTumor Suppressor ProteinsCre recombinaseIntegrasesTumor Suppressor Proteins

Identifiers

PMID21913308
PMCPMC3273649
OpenAlexW2093272781

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.